Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells

Naoki Osada; Jiro Kikuchi; Yosuke Okada; Sae Matsuoka; Kazuhiro Morishita; Hideki Nakasone; Yusuke Furukawa

doi:10.1371/journal.pone.0309533

Loading metrics

Open Access

Peer-reviewed

Research Article

Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells

Naoki Osada,

Roles Data curation, Writing – original draft

Affiliation Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
⨯
Jiro Kikuchi ,

Roles Data curation, Writing – original draft, Writing – review & editing

* E-mail: kiku-j@jichi.ac.jp

Affiliation Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan

https://orcid.org/0009-0004-8791-3263

⨯
Yosuke Okada,

Roles Resources

Affiliations Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
⨯
Sae Matsuoka,

Roles Data curation

Affiliation Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
⨯
Kazuhiro Morishita,

Roles Resources

Affiliations HTLV-1/ATL Research, Education and Medical Facility, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, Project for Advanced Medical Research and Development, Project Research Division, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan
⨯
Hideki Nakasone,

Roles Resources

Affiliations Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
⨯
Yusuke Furukawa

Roles Supervision

Affiliations Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, Center for Medical Education, Teikyo University of Science, Tokyo, Japan
⨯

Cytotoxicity of bendamustine, alone and in combination with novel agents, toward adult T-cell leukemia cells

Naoki Osada,
Jiro Kikuchi,
Yosuke Okada,
Sae Matsuoka,
Kazuhiro Morishita,
Hideki Nakasone,
Yusuke Furukawa

Published: September 30, 2024
https://doi.org/10.1371/journal.pone.0309533

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cytotoxicity
Is the Subject Area "Cytotoxicity" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Analysis of variance
Is the Subject Area "Analysis of variance" applicable to this article?

Thanks for your feedback.
Japan
Is the Subject Area "Japan" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
MTT assay
Is the Subject Area "MTT assay" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.